Replace VSDH pricing model

When VSDH's wrapped pricing breaks — replace it with pass-through

VS Digital Health, commonly known as VSDH, wraps clinic-facing landed cost in partner agreements, wholesale catalog pricing, and revenue share rather than showing resolved per-vial 503A cost in a self-serve cart. Replacing VSDH with pass-through pricing makes sense when that model stops fitting how a clinic runs margin — you delay quoting cash-pay patients, cannot separate drug cost from platform economics, or cannot model refill-day throughput without renegotiating. A pass-through platform like Fizy Health shows per-vial 503A landed cost on each catalog and cart line before checkout, with a disclosed facilitation fee at payment.

If you cannot see per-vial cost at the moment you quote a patient, this page explains how pass-through pricing differs from VSDH's partner and revenue-share model — and the concrete signals that it is time to replace it.

Compare Fizy Health vs VSDH

Proudly Partnered With

Partner pricing versus pass-through, plainly

VSDH's model combines wholesale catalog pricing to partners with clinic-facing economics that often include revenue share and custom quotes rather than public per-vial rates on vsdigitalhealth.com. Its public FAQ directs clinics to request a custom quote as of June 2026. That can produce competitive rates at volume inside a white-label or ConnectRxCare relationship — a real strength when launching a D2C brand. The cost is visibility: landed per-vial cost may not appear at the moment you quote a semaglutide or tirzepatide patient, and separating drug cost from platform margin requires reading partner agreements rather than reading a cart line.

Pass-through pricing inverts that for clinic ops. With Fizy Health, resolved 503A landed cost appears on each catalog and cart line before checkout, and the platform's margin is a disclosed facilitation fee at payment — not an opaque layer inside the vial cost or a revenue-share stack. For a clinic quoting cash-pay patients daily, the price you quote and the price you pay trace to the same visible number. VSDH-as-supplier and VSDH-as-platform remain distinct: you may keep overlapping fulfillment while replacing how pricing surfaces to your team.

Signs it is time to replace VSDH's pricing model

Replace wrapped partner pricing when lack of upfront visibility actively slows your business. Common signals: you delay quoting a new patient because you are waiting on a rate from a sales or partner conversation; you cannot confidently set cash-pay prices because landed cost is not visible at point of sale; you suspect margin lives in revenue share but cannot separate drug cost from platform economics; or your volume shifted and you are unsure current VSDH partner rates still reflect reality without reopening negotiation.

Operational signals compound the financial ones: ConnectRxCare and VSDH API flows are built for pharmacy fulfillment, not batch multi-patient checkout — so pricing opacity pairs with refill-day friction. A pass-through platform like Fizy Health pairs visible per-vial cost with pre-submit cart validation, so the workflow that shows margin also catches SIG and licensure errors before payment. If none of these apply — your VSDH white-label stack, partner rates, and refill workflow are clean — staying may be correct. Replace the model when visibility and batch ops, not the vendor name, are the constraint.

Keep VSDH partner pricing, or replace it with pass-through?

Keep VSDH pricing if

VSDH

Your partner wholesale rates and white-label economics already win.

  • You still need VSDH's full white-label consumer stack — apps, telemedicine, and branded pharmacy.
  • Your VSDH partner rates beat pass-through cost on the SKUs you order most and you do not need per-vial cost at quote time.
  • Revenue share and annual subscription fit your D2C margin model better than clinic ops software.
Replace with Fizy Health if

Fizy Health

You need the per-vial number before you quote — every time.

  • You quote cash-pay patients daily and need landed 503A cost visible in catalog and cart before checkout.
  • You want drug cost and a disclosed facilitation fee separated — not hidden in revenue share or partner markup.
  • You want pre-submit validation paired with visible pricing so paid orders stop getting rejected.
FAQ

Common questions about replacing VSDH with pass-through pricing.

  • Definition

    What does pass-through pricing mean for clinic ordering?

    Pass-through pricing means the drug cost you pay is what the 503A pharmacy charges, shown per vial on each catalog and cart line before checkout, with the platform's margin disclosed separately as a facilitation fee at payment rather than hidden inside the vial cost or revenue share.

  • Comparison

    How is pass-through different from VS Digital Health (VSDH) pricing?

    VSDH uses wholesale catalog pricing to partners with clinic-facing landed cost often wrapped in revenue-share agreements and custom quotes. Pass-through pricing on Fizy Health shows resolved 503A landed cost up front, with a disclosed facilitation fee, so you quote on visible numbers without a sales gate.

  • Trigger

    When should I replace VSDH's pricing model?

    Replace it when lack of upfront visibility slows you down: you delay quoting while waiting on partner rates, you cannot set cash-pay prices confidently because landed cost is not visible at point of sale, or you cannot separate drug cost from revenue-share economics.

  • Strengths

    Is VSDH partner pricing ever the better choice?

    Yes. Negotiated wholesale and revenue-share economics can produce strong rates at volume inside a white-label or ConnectRxCare relationship — a genuine VSDH strength when launching D2C. If partner rates already beat pass-through on top SKUs and you do not need pricing at quote time, staying may be correct.

  • Validation

    Does pass-through pricing help with rejected orders?

    On Fizy Health, visible pricing is paired with pre-submit cart validation. The same workflow that shows per-vial margin also catches invalid SIGs, prescriber state mismatches, and stock gaps before you pay, so fewer paid orders get rejected by the pharmacy.

  • Proof

    How do I verify pass-through pricing is actually cheaper than VSDH?

    Open the Fizy Health catalog and cart for your highest-volume GLP-1 and hormone lines and compare per-vial pass-through cost against landed cost from your current VSDH partner pricing. If it does not beat your VSDH rates, do not switch.

Sources reviewed June 2026

  • VS Digital Health public website and FAQ (vsdigitalhealth.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See pass-through pricing on your top SKUs — no quote required.

Compare landed cost on semaglutide and tirzepatide, run one validated batch cart, and decide with real numbers. Free to start.